glp-1 brain effects Mechanisms of in Modulating Craving and Addiction: Neurobiological and Translational Insights GLP-1 mimetics and cognition -

The difference often comes down to lifestyle habits

Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: a systematic review and meta-analysis of randomized controlled trials

Retatrutide is not approved for clinical use and is available only through clinical trials

Clinicians should exercise caution in patients with a history of pancreatitis or gastroparesis, inflammatory bowel disease, other gut motility disorders, medullary thyroid carcinoma, or Multiple Endocrine Neoplasia syndrome type 2, and pause therapy when clinically indicated, such as before anesthesia

doi: 10.3389/fendo.2025.1593334

For some researchers, 4mg provides sufficient appetite suppression to achieve their goals without further escalation